Incretin based therapies for the treatment of obesity related diseases npj Metabolic Health and Disease 99.9% Purity COA Testing Report Mazdutide Cagrilintide Retatrutide Lyophilized Powder CAS 2381089 83 2 Weight Loss Peptide Research Reagents Ochi Biotech Co., Limited. The evolving landscape of obesity pharmacotherapy Nature Reviews Drug Discovery Pharmacologic Disruption: How Emerging Weight Loss Therapies Are Challenging Bariatric Surgery Guidelines In Chinese adults with overweight or obesity, once weekly #GLP glucagon agonist mazdutide, at a dose of 4 mg or 6 mg for 32 48 weeks, led to clinically relevant #weightloss in the Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants Gabe 2024 Diabetes, Obesity and Metabolism Wiley Online Library